STAT5A and cancer: STAT3 and STAT5 are of particular interest because they are not only activated by a wide variety of ligands that control proliferation, survival, cell–cell communication, adhesion, and angiogenesis [6], but their dysregulation also facilitate tumor progression in various human cancers, particularly leukemia and lymphomas [7, 8] (Table 1).